Investigating immune responses to COVID-19 through antibody testing
Frederick National Laboratory for Cancer Research (FNLCR) Center for SARS-CoV-2 Serological Sciences
This study is all about improving tests that check for COVID-19 antibodies, helping people understand their immunity after getting infected or vaccinated, so everyone can stay safer and healthier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10582502 on NIH RePORTER |
What this research studies
This research focuses on understanding how the immune system responds to COVID-19 by developing highly accurate tests to detect antibodies against the virus. The project aims to enhance national testing capabilities for SARS-CoV-2 antibodies and to conduct in-depth studies on immune responses following infection or vaccination. Patients may benefit from improved testing methods that can provide insights into their immunity status and inform public health strategies. The research involves collaboration among various centers to ensure comprehensive data collection and analysis.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who have been infected with SARS-CoV-2 or vaccinated against COVID-19.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or have not received a COVID-19 vaccine may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective testing and understanding of immunity against COVID-19, benefiting patients through better-informed health decisions.
How similar studies have performed: Other research initiatives have successfully developed serological assays for various viruses, indicating a promising potential for this approach in understanding COVID-19 immunity.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.